Transaction and operating materials across both entities
Synthetic M&A intelligence preview
See what completed M&A intelligence looks like.
This preview illustrates the opportunity summary, representative findings, source evidence, prioritisation, and executive-ready decision support a client can receive.
Fictional transaction · Synthetic documents, figures, and findings · For illustration only
Completed Analysis Overview
Decision-ready M&A intelligence at a glance
A concise first view of the evidence reviewed, value creation opportunities identified, and issues requiring management attention.
Across cost, revenue, working capital, and risk
Indicative annual value and cash-release opportunity
Items requiring management attention or further validation
Time to first decision-ready view
2 business days
The synthetic example shows how acquisition data can be organized into a structured first view for faster decision support.
Representative Findings
Opportunities presented for decision, not display
Each finding combines the business opportunity, indicative value, supporting evidence, and relative priority in one reviewable record.
01 · Cost Opportunity
Vendor rate harmonisation
Immediate priorityOpportunity
Both entities purchase comparable services from the same supplier under different commercial terms. The stronger existing rate provides a credible basis for consolidation at renewal.
Evidence linked
Vendor_Agreement.pdf · Section 3; Supplier_Contracts.xlsx · Rates tab
Estimated value$0.32M–$0.40MEstimated annual savings
Indicative synthetic range. Final values depend on evidence quality, validation, and engagement assumptions.
02 · Revenue Opportunity
Cross-sell into an underpenetrated customer segment
High priorityOpportunity
The target customer portfolio contains a defined group with no current exposure to the acquirer’s complementary offering, creating a focused commercial opportunity.
Evidence linked
Customer_Portfolio.xlsx · Coverage tab; Product_Catalogue.pdf · Page 12
Estimated value$1.2M–$1.5MEstimated annual revenue
Indicative synthetic range. Final values depend on evidence quality, validation, and engagement assumptions.
03 · Working Capital Opportunity
Payment-term alignment
High priorityOpportunity
Supplier terms vary materially across the two entities. Aligning selected categories to the stronger documented position could improve cash conversion without changing core operations.
Evidence linked
Supplier_Terms.xlsx · DPO analysis; Treasury_Pack.pdf · Page 8
Estimated value$1.8M–$2.2MEstimated cash release
Indicative synthetic range. Final values depend on evidence quality, validation, and engagement assumptions.
04 · Contractual & Legal Exposure
Customer SLA exposure
Urgent priorityOpportunity
Several material customer agreements contain service commitments that are not consistently reflected in current performance reporting, creating avoidable contractual exposure.
Evidence linked
Master_Customer_Agreements.pdf · Clauses 7.2 and 9.4; Service_Performance.xlsx · SLA tab
Estimated value$0.6M–$0.9MPotential exposure identified
Indicative synthetic range. Final values depend on evidence quality, validation, and engagement assumptions.
05 · Cost Opportunity
Overlapping software contracts
Medium priorityOpportunity
The combined application portfolio includes overlapping collaboration and workflow tools, with renewal dates that create a practical sequence for rationalisation.
Evidence linked
Software_Register.xlsx · Active licences; Renewal_Calendar.pdf · Pages 4–6
Estimated value$0.45M–$0.60MEstimated annual savings
Indicative synthetic range. Final values depend on evidence quality, validation, and engagement assumptions.
Traceability Example
From source document to quantified value
A conclusion is easier to validate and defend when the supporting evidence remains visible.
Supplier_Contracts.xlsx
Commercial terms for the same service across both entities
$45 vs. $38 per unit
Comparable scope, supplier, and contracted service level
Harmonise vendor rates
Use the stronger documented terms as the renewal position
$0.32M–$0.40M
Indicative annual opportunity, subject to commercial validation
Executive Output
A management-ready view of what matters next
Findings are brought together into an executive summary that separates opportunity, risk, and immediate management focus.
Executive summary · Synthetic transaction
Prepared for management reviewPrioritised value creation and risk review
Prioritised opportunities
01
Align supplier pricing at the next commercial renewal
02
Launch validation of the cross-sell customer cohort
03
Prepare a payment-term alignment plan by category
Key risks
SLA obligations require owner confirmation before close
Cross-sell value depends on customer eligibility and sales capacity
Cash-release timing depends on supplier negotiation sequencing
Recommended focus
Confirm commercial owners for immediate opportunities
Close the outstanding evidence gaps
Move validated findings into integration planning
The indicative value range combines recurring annual opportunity and potential cash release. Risk exposure is presented separately so that unlike measures are not treated as directly additive.
Client Outcome
What the completed analysis provides
Visibility
A structured view of where value exists across the transaction.
Confidence
Findings supported by visible evidence, assumptions, and review status.
Speed
A decision-ready first view for transaction review.
Evidence-backed decisions
Priorities that investment committees and operating teams can inspect and defend.
See the full example
Talk to Our TeamExplore what Velintis M&A intelligence could look like for your transaction.